Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00071760

Contacts


Contact: US GSK Clinical Trials Call Center	877-379-3718

Locations


United States, Florida
	GSK Investigational Site	Withdrawn
	Jacksonville, Florida, United States, 32209

United States, New York
	GSK Investigational Site	Withdrawn
	New York, New York, United States, 10016

United States, North Carolina
	GSK Investigational Site	Active, not recruiting
	Durham, North Carolina, United States, 27705

Argentina
	GSK Investigational Site	Terminated
	Buenos Aires, Argentina, 1405

Mexico
	GSK Investigational Site	Completed
	Mexico, Mexico, 6720
	GSK Investigational Site	Completed
	Mexico, D.F., Mexico, 06720

Portugal
	GSK Investigational Site	Terminated
	Almada, Portugal, 2805-267
	GSK Investigational Site	Terminated
	Lisboa, Portugal, 1649-035
	GSK Investigational Site	Withdrawn
	Amadora, Portugal, 2700

Puerto Rico
	GSK Investigational Site	Completed
	San Juan, Puerto Rico, 00935

Russian Federation
	GSK Investigational Site	Not yet recruiting
	Krasnojarsk, Russian Federation, 660049
	GSK Investigational Site	Recruiting
	Moscow, Russian Federation, 105275
	GSK Investigational Site	Recruiting
	Moscow, Russian Federation, 129110
	GSK Investigational Site	Recruiting
	St. Petersburg, Russian Federation, 196645

South Africa
	GSK Investigational Site	Recruiting
	Gauteng, South Africa, 2013

South Africa, KwaZulu- Natal
	GSK Investigational Site	Active, not recruiting
	Durban, KwaZulu- Natal, South Africa, 4013

South Africa, Western Province
	GSK Investigational Site	Recruiting
	Parow Valley, Western Province, South Africa, 7505

Sponsors and Collaborators

GlaxoSmithKline

Investigators


Study Director:	GSK Clinical Trials, MD	GlaxoSmithKline